Mesenchymal Stem Cells Market (By Product & Services: Products, Services; By Type: Autologous, Allogeneic; By Source of Isolation: Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues; By Indication:Bone And Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others; By Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Mesenchymal Stem Cells Market, By Product & Services Type

7.1. Mesenchymal Stem Cells Market, by Product & Services Type, 2021-2030

7.1.1. Products

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Services

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Mesenchymal Stem Cells Market, By Product Type

8.1. Mesenchymal Stem Cells Market, by Product Type, 2021-2030

8.1.1. Autologous

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Allogeneic

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Mesenchymal Stem Cells Market, By Source of Isolation Type 

9.1. Mesenchymal Stem Cells Market, by Source of Isolation Type, 2021-2030

9.1.1. Bone Marrow

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Cord Blood

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. UV Peripheral Blood

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Fallopian Tube

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Fetal Liver

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Lung

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Adipose Tissues

9.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Mesenchymal Stem Cells Market, By Indication Type

10.1. Mesenchymal Stem Cells Market, by Indication Type, 2021-2030

10.1.1. Bone And Cartilage Repair

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cardiovascular Disease

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Inflammatory And Immunological Diseases

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Liver Diseases

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Cancer

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. GvHD

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Mesenchymal Stem Cells Market, By Application Type

11.1. Mesenchymal Stem Cells Market, by Application, 2021-2030

11.1.1. Disease Modelling

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Drug Development & Discovery

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Stem Cell Banking

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Tissue Engineering

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Toxicology Studies

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Others

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Mesenchymal Stem Cells  Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.1.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.1.4. Market Revenue and Forecast, by Indication (2017-2030)

12.1.5. Market Revenue and Forecast, by Application (2017-2030)

12.1.6. U.S.

12.1.6.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Indication (2017-2030)

12.1.7. Market Revenue and Forecast, by Application (2017-2030) 

12.1.8. Rest of North America

12.1.8.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.1.8.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.1.8.4. Market Revenue and Forecast, by Indication (2017-2030)

12.1.8.5. Market Revenue and Forecast, by Application (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.2.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.2.4. Market Revenue and Forecast, by Indication (2017-2030) 

12.2.5. Market Revenue and Forecast, by Application (2017-2030) 

12.2.6. UK

12.2.6.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.2.7. Market Revenue and Forecast, by Indication (2017-2030) 

12.2.8. Market Revenue and Forecast, by Application (2017-2030) 

12.2.9. Germany

12.2.9.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.9.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.2.10. Market Revenue and Forecast, by Indication (2017-2030)

12.2.11. Market Revenue and Forecast, by Application (2017-2030)

12.2.12. France

12.2.12.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.12.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.2.12.4. Market Revenue and Forecast, by Indication (2017-2030)

12.2.13. Market Revenue and Forecast, by Application (2017-2030)

12.2.14. Rest of Europe

12.2.14.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

12.2.14.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.2.14.4. Market Revenue and Forecast, by Indication (2017-2030)

12.2.15. Market Revenue and Forecast, by Application (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.3.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.3.4. Market Revenue and Forecast, by Indication (2017-2030)

12.3.5. Market Revenue and Forecast, by Application (2017-2030)

12.3.6. India

12.3.6.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Indication (2017-2030)

12.3.7. Market Revenue and Forecast, by Application (2017-2030)

12.3.8. China

12.3.8.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Indication (2017-2030)

12.3.9. Market Revenue and Forecast, by Application (2017-2030)

12.3.10. Japan

12.3.10.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.10.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.3.10.4. Market Revenue and Forecast, by Indication (2017-2030)

12.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

12.3.11. Rest of APAC

12.3.11.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

12.3.11.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.3.11.4. Market Revenue and Forecast, by Indication (2017-2030)

12.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.4.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.4.4. Market Revenue and Forecast, by Indication (2017-2030)

12.4.5. Market Revenue and Forecast, by Application (2017-2030)

12.4.6. GCC

12.4.6.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Indication (2017-2030)

12.4.7. Market Revenue and Forecast, by Application (2017-2030)

12.4.8. North Africa

12.4.8.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Indication (2017-2030)

12.4.9. Market Revenue and Forecast, by Application (2017-2030)

12.4.10. South Africa

12.4.10.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.10.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.4.10.4. Market Revenue and Forecast, by Indication (2017-2030)

12.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

12.4.11. Rest of MEA

12.4.11.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

12.4.11.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.4.11.4. Market Revenue and Forecast, by Indication (2017-2030)

12.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.5.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.5.4. Market Revenue and Forecast, by Indication (2017-2030)

12.5.5. Market Revenue and Forecast, by Application (2017-2030)

12.5.6. Brazil

12.5.6.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Indication (2017-2030)

12.5.7. Market Revenue and Forecast, by Application (2017-2030)

12.5.8. Rest of LATAM

12.5.8.1. Market Revenue and Forecast, by Product & Services (2017-2030)

12.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

12.5.8.3. Market Revenue and Forecast, by Source of Isolation (2017-2030)

12.5.8.4. Market Revenue and Forecast, by Indication (2017-2030)

12.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Cell Applications, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Axol Biosciences Ltd.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Cytori Therapeutics Inc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. STEMCELL Technologies Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Cyagen Biosciences Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Celprogen Inc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. BrainStorm Cell Therapeutics Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Stemedica Cell Technologies Inc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Merck KGaA (MilliporeSigma)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. Smith+Nephew

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

13.12. Lonza AG

13.12.1. Company Overview

13.12.2. Product Offerings

13.12.3. Financial Performance

13.12.4. Recent Initiatives

13.13. PromoCell GmbH

13.13.1. Company Overview

13.13.2. Product Offerings

13.13.3. Financial Performance

13.13.4. Recent Initiatives

13.14. ScienCell Research Laboratories

13.14.1. Company Overview

13.14.2. Product Offerings

13.14.3. Financial Performance

13.14.4. Recent Initiatives

13.15. American Type Culture Collection

13.15.1. Company Overview

13.15.2. Product Offerings

13.15.3. Financial Performance

13.15.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms